Results
1 -
10 of
16Shirai Junya, Yoshikawa Takeshi, Yamashita Masayuki, Yamamoto Yasuharu, Kawamoto Makiko, Tarui Naoki, Kamo Izumi, Hashimoto Tadatoshi, Ikeura Yoshinori.
Design, structure–activity relationship, and highly efficient asymmetric synthesis of 3-phenyl-4-benzylaminopiperidine derivatives as novel neurokinin-1 receptor antagonists, Bioorganic & Medicinal Chemistry, 2011 Di Fabio Romano, Griffante Cristiana, Alvaro Giuseppe, Pentassuglia Giorgio, Pizzi Domenica A., Donati Daniele, Rossi Tino, Guercio Giuseppe, Mattioli Mario, Cimarosti Zadeo, Marchioro Carla, Provera Stefano, Zonzini Laura, Montanari Dino, Melotto Sergio, Gerrard Philip A., Trist David G., Ratti Emiliangelo, Corsi Mauro.
Discovery Process and Pharmacological Characterization of 2-(S)-(4-Fluoro-2-methylphenyl)piperazine-1-carboxylic Acid [1-(R)-(3,5-Bis-trifluoromethylphenyl)ethyl]methylamide (Vestipitant) as a Potent, Selective, and Orally Active NK1Receptor Antagonist, Journal of Medicinal Chemistry, 2009 Antidepressant-like effects of agomelatine, melatonin and the NK1 receptor antagonist GR205171 in impulsive-related behaviour in rats, Psychopharmacology Mutagenesis and Knockout Models: NK1 and Substance P, Anxiety and Anxiolytic Drugs Inhibition of neurogenic inflammation in abortive migraine treatment, Migraine: A Neuroinflammatory Disease? The Role of Tachykinins and the Tachykinin NK1 Receptor in Nausea and Emesis, Tachykinins Substance P (NK1) Receptor Antagonistsu2014Analgesics or Not?, Tachykinins Postoperative Nausea and Vomiting, Problems of the Gastrointestinal Tract in Anesthesia, the Perioperative Period, and Intensive Care Role of NK1 receptors on cisplatin-induced nephrotoxicity in the rat, Naunyn-Schmiedeberg's Archives of Pharmacology